Vioxx report hits at Merck

April 16th, 2008 by

admin

The pharmaceuticals assemble downplayed the risks related with the painkiller in reports in scholarly journals and primeval submissions to US regulators, says a study

Tags: Journals, Risk

Posted in Pharmaceuticals |

Recent Posts

Low-grade gliomas in adults
Anaplastic oligodendroglioma
New fifth edition serum-free light chain analysis
Final data from phase 1 investigator-sponsored trial of oncophage® cancer vaccine in glioma presented at the society for neuro-oncology’s annual meeting
Human bre1 is an e3 ubiquitin ligase for ebp1 tumor suppressor.
A pilot study of human interferon {beta} gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes
Bax and bid act in synergy to bring about t11ts-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation
Free teleconference on latest glioma treatments: a program for patients and families presented by: dr. howard fine
Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor
In vitro antitumor mechanisms of various scutellaria extracts and constituent flavonoids

Oriollo Health News

Vioxx report hits at Merck

Related posts

Recent Posts

Categories

Archives:

Search: